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A role for δ-catenin in synaptic regulation

Li Yuan, Ph.D.
University of Nebraska, 2017
Supervisor: Jyothi Arikkath, Ph.D.
The cadherin-catenin complex regulates cell-cell adhesion and signal transduction in epithelial cells. It is becoming increasingly evident that components of the complex regulate various aspects of neuronal architecture and function. δ-catenin is a cytosolic component of the cadherin-catenin complex and is predominantly expressed in the
central nervous system. Loss of CTNND2, which encodes δ-catenin, is associated with
intellectual disability and mutations in CTNND2 have been identified in autism, suggesting that δ-catenin is a critical component of the molecular machinery underlying neural
circuit function. We have previously demonstrated that δ-catenin regulates multiple aspects of synaptic and dendritic development, including dendritic arborization, spine density, architecture and function, consistent with the protein being a key player in regulating
neuronal circuit formation and function in the developing brain.
We have identified novel forms of δ-catenin that participate in synaptic regulation.
Our data indicate that novel forms of δ-catenin that include either the N-terminal
(DcatNT) or C-terminal (DcatCT) regions are expressed in different regions of the brain.
These forms are generated via two mechanisms, one of which involves NMDA receptor
(NMDAR), Ca2+ and calpain-dependent cleavage while the other mechanism is NMDARindependent. The DcatCT and NT forms generated in an NMDAR-independent manner
are differentially dependent on the lysosome for their generation. Functionally, loss of
the domain containing the predicted sites allowing for generation of DcatCT and NT per-
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turbs the density of a subpopulation of dendritic protrusions. Thus, our data provide evidence for a key role for δ-catenin in regulating a subset of dendritic protrusions, and implicate critical functional roles for δ-catenin in neural circuit wiring in the developing hippocampus.

iv
Table of Contents

Title Page ......................................................................................................................... i
Acknowledgement ............................................................................................................ i
Abstract ........................................................................................................................... ii
Table of Contents ........................................................................................................... iv
List of Figures ................................................................................................................ vii
List of Tables ................................................................................................................... x
List of Abbreviations ....................................................................................................... xi

Introduction .................................................................................................................... 1
The cadherin-catenin cell adhesion complex in central neurons.................................. 1
The p120ctn family of proteins .................................................................................... 1
δ-catenin ..................................................................................................................... 2
The expression and localization of δ-catenin............................................................... 2
δ-catenin in regulation of synaptic density, architecture, plasticity and function ........... 3
Emerging roles for CTNND2 in neurodevelopmental and neurological disorders ........ 8

CHAPTER 1

Materials and methods..........................................................................10

Animals .........................................................................................................................11
Cell culture and transfection ..........................................................................................11
Plasmids........................................................................................................................12
Pharmacological reagents .............................................................................................14
Lysate preparation and immunoblotting .........................................................................15

v
In vitro cleavage assay ..................................................................................................17
Calculate molecular weight ............................................................................................17
δ-catenin purification .....................................................................................................18
Immunocytochemistry and microscopy ..........................................................................18
Statistics ........................................................................................................................19
Immunoblot and morphology analysis ........................................................................19
Fraction and approximate density for each population ...............................................20
Determine P1 density threshold .................................................................................21
Above threshold fraction comparison .........................................................................21

CHAPTER 2

DcatCT and NT are two novel forms of δ-catenin..................................22

Two novel isoforms of δ-catenin in the brain ..................................................................23
DcatCT and NT are generated via a calpain-dependent mechanism .............................27

CHAPTER 3

DcatCT and NT can be generated by two independent mechanisms ....33

DcatCT and NT can be generated in an NMDAR-dependent manner by calpain cleavage
......................................................................................................................................34
The basal generation of DcatCT and NT is NMDAR-independent .................................38

CHAPTER 4

The functional role of δ-catenin cleavage in dendritic protrusion

development

51

Mapping the calpain cleavage sites on δ-catenin ...........................................................52
δ-catenin affects dendritic protrusion density .................................................................55

Discussion .....................................................................................................................63

vi
Different forms of δ-catenin ........................................................................................63
Differential regulation of DcatCT and NT levels by degradation .................................65
Regulation of dendritic protrusions by proteolytic cleavage of δ-catenin.....................65
Future directions ........................................................................................................68
Identify regulatory mechanisms for δ-catenin cleavage ..............................................68
Identify the functional consequence for calpain-mediated cleavage of δ-catenin in
excitotoxicity ...........................................................................................................68
Identify the mechanism for the basal generation of DcatCT and NT .......................69
Identify additional functional roles for DcatCT and NT ............................................69
Implications for autism ............................................................................................70

Reference......................................................................................................................71

vii
List of Figures

Introduction
Figure 1: Schematic of δ-catenin-ABP/GRIP-AMPAR complex.

CHAPTER 2 DcatCT and NT are two novel forms of δ-catenin
Figure 2: The expression of two novel forms of δ-catenin, DcatNT and DcatCT, in the
brain.

Figure 3: The expression of DcatNT and CT in different brain regions.

Figure 4: The generation of DcatCT and N-terminal fragments can be recapitulated in lysates from δ-catenin-transfected HEK cells.

Figure 5: The generation of DcatCT and NT is chelator-dependent in an in vitro cleavage
assay.

Figure 6: The generation of DcatCT and NT is mediated by calpain in an in vitro cleavage assay.

CHAPTER 3 DcatCT and NT can be generated by two independent mechanisms

viii
Figure 7: Glutamate induces NMDAR- and calpain-dependent generation of DcatCT and
NT.
Figure 8: NMDA induces Ca2+-influx and calpain-mediated cleavage of δ-catenin.

Figure 9: DcatCT consists of two forms, DcatCTI and II.

Figure 10: Inhibition of neural activity has no effect on the basal level of DcatCT and NT.

Figure 11: Inhibition of NMDAR has no effect on the basal level of DcatCT and NT.

Figure 12: Inhibition of L-type VGCC has no effect on the basal level of DcatCT and NT.

Figure 13: Disrupt the normal function of lysosome decreases the basal level of DcatNT,
but not CT.

Figure 14: Inhibition of cathepsin B decreases the basal level of DcatNT, but not CT.

Figure 15: The basal and NMDAR-dependent forms of DcatCT/NT are generated in two
independent pathways.

CHAPTER 4 The functional role of δ-catenin cleavage in dendritic protrusion development
Figure 16: Mapping the calpain cleavage sites on δ-catenin by in vitro cleavage assay.
Figure 17: Cleavage of δ-catenin regulates the dendritic protrusion density.

ix
Figure 18: Cleavage of δ-catenin regulates the upper limit of the density of P1 protrusions.

x
List of Tables

CHAPTER 1 Materials and methods
Table 1: Primers for truncated δ-catenin.

xi
List of Abbreviations

AMPAR

α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor

Asco

Ascomycine

ARM

Armadillo

Baf

Bafilomycin A1

CA

CA-074 Me, CA-074 methyl ester

CDK5

Cyclin Dependent Kinase 5

DcatCT

δ-catenin C-terminus

DcatNT

δ-catenin N-terminus

Glut

Glutamate

GRIP

Glutamate receptor interacting protein

Het

Heterozygous

Homo

Homozygous

L-NAME

Nω-Nitro-L-arginine methyl ester

Lact

Lactacystin

LE

Long exposure

LTP

Long-term potentiation

MK

(+)-MK 801

xii
MDL

MDL28170

Nimo

Nimodipine

NLS

Nuclear localization signal

NMDA

N-Methyl-D-aspartic acid

NMDAR

NMDA receptor

NOS

Nitric oxide synthase

P1/2/3

Population 1/2/3

PSD95

Postsynaptic density protein 95

SBDP

Spectrin breakdown product

SE

Short exposure

shRNA

Short hairpin RNA

Thap

Thapsigargin

TTX

Tetrodotoxin

VGCC

Voltage-dependent calcium channel

WT

Wild-type

1

Introduction*

The cadherin-catenin cell adhesion complex in central neurons
Cadherins are transmembrane proteins that mediate cell-cell adhesion in a variety
of cell types. More recently, it has become clear that they have extensive functional roles
in neurons and are associated with multiple neuronal functional roles including adhesion
and synaptic plasticity. Their functional roles are of particular significance in multiple aspects of neuronal morphology, synaptic structure, synaptic efficacy and molecular processes related to learning and memory [1–3]. Cadherins mediate adhesion across synapses via homophilic trans-interactions across the synaptic cleft [2]. The cytosolic intracellular terminal of cadherins is associated with a variety of proteins, collectively called catenins. Of these, β-catenin is perhaps the most well studied and several studies indicate critical roles for this protein in a variety of neuronal phenotypes including pre- and postsynaptic development, memory and addiction [4–7]. A group of catenins associated with the
classical cadherins also include members of the p120ctn family of proteins. The p120ctn
family of proteins form a family distinct from the β-catenin and α-catenin families and bind
to cadherin at a site distinct from the β-catenin binding site [8]. Over the last several years,
it has become obvious that the functional roles of the p120ctn family of proteins are quite
diverse and include both cadherin-dependent and -independent functional roles in various
aspects of neuronal morphogenesis.

The p120ctn family of proteins
The p120ctn family includes 4 proteins encoded by four independent genes. These
include p120ctn (encoded by CTNND1), δ-catenin (also called NPRAP or neurojungin [9],
encoded by CTNND2), p0071 (plakophilin-4, encoded by PKP4) and ARVCF (encoded by
* Introduction is modified from Seminars in Cell & Developmental Biology, Vol 69, L
Yuan, J Arikkath, Functional roles of p120ctn family of proteins in central neurons, 7082, Copyright (2017), with permission from Elsevier.
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ARVCF). Evolutionarily, they are generated from an ancient ‘δ-catenin-like’ gene and divided into two major classes, one of which comprises p0071 and δ-catenin, while the other
includes p120ctn and ARVCF [10]. p120ctn, ARVCF and p0071 are expressed in central
neurons and widely distributed in non-neuronal tissues [11–14]. δ-catenin is unique in that
it has a more restricted expression to central neurons [9,15].

δ-catenin
Similar to other members of the p120ctn family, δ-catenin includes an N-terminal
domain, a series of 9 armadillo (ARM) repeats and C-terminal domain. The N-terminal
domain of δ-catenin bears a coil-coil domain, while the end of the C-terminal domain contains a PDZ-binding motif.
So far, two splice variants for δ-catenin are known in mouse [9]. One of these
includes a 25 aa insertion at the beginning of the first helix of ARM 7. Both isoforms are
expressed in various brain regions, and in both neuron and glia [16]. While no functional
differences between the two isoforms are known, the 25 aa cassette is localized spatially
proximal to the insert region on the arch of the ARM domain [17], suggesting it may regulate the structure and function of the insert region.

The expression and localization of δ-catenin
δ-catenin is widely expressed in different regions of the brain [9,16], both during
early development and in the mature brain [18–21]. δ-catenin is also expressed in neural
progenitor cells, although their functional roles in these cells remains incompletely characterized [22,23]. In addition, recent studies combining electrophysiological profiling with
single-cell RNAseq analysis demonstrate the expression of δ-catenin is significantly lower
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in burst-spiking pyramidal cells compared to regular-spiking pyramidal cells in the subiculum [20], suggesting neuron type specific expression patterns and functional roles. Further,
analysis of the primary visual cortical region in mice indicated that the expression of δcatenin is enriched in inhibitory somatosensory neurons [24,25].
In primary neurons, δ-catenin is localized to growth cones [26], dendritic segments
and postsynaptic terminals in central neurons [27,28]. It is not entirely clear if δ-catenin is
also localized at presynaptic terminals.

δ-catenin in regulation of synaptic density, architecture, plasticity and function
Given the key links between the cadherin-catenin cell adhesion complex and the
actin cytoskeleton, it is not surprising that δ-catenin regulates dendritic development, synaptic density and architecture in neurons.
δ-catenin has been shown as a key regulator for dendritic development. Loss of δcatenin during dendritic development reduces dendritic arbors [27]; in contrast, overexpression of δ-catenin increases the branch number [29,30].
Compared to the dendritic phenotype, the effects of loss of δ-catenin on excitatory
spine density remain somewhat confusing. Studies indicate that overexpression of δcatenin in mature primary hippocampal neurons increases the density of synapses [31].
These abilities of δ-catenin to enhance spine density could be inhibited by the use of a
dominant negative Rac construct [31], indicating the ability of δ-catenin to influence spine
and synapse density is regulated indirectly through small G proteins, which in turn regulate
the actin cytoskeleton. Conversely, the authors demonstrated that loss of δ-catenin using
siRNA-mediated knockdown leads to a decrease in the density of spines and synapses
[31]. Importantly, these reduced densities could be rescued by the introduction of an
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siRNA-resistant construct of δ-catenin, confirming specificity [31]. These studies are also
supported by other published studies which indicate that overexpression of δ-catenin promotes an increase in the density of spines and synapses in primary hippocampal neurons
[32]. However, these studies are in direct contrast to another study in primary hippocampal neurons in which loss of δ-catenin leads to an increase in the density and function of
excitatory synapses both with specific shRNA knockdown and in primary neurons from δcatenin N-term mice, a mouse model that includes an N-terminal truncated form of δcatenin [33,34]. Further, these abilities of δ-catenin were dependent on its ability to cooperate with PDZ domain containing regulators via its PDZ-binding motif, but like p120ctn, it
is also independent of cadherin binding [33,34]. It is unclear how these contrasting results
can be reconciled. One likely possibility is that since δ-catenin is a component of the cadherin-catenin cell adhesion complex, the ability of δ-catenin to influence spine and synapse density is related to the density of neurons in the culture. Other possibilities include
splice variant specific effects or the levels of δ-catenin or neuron subtype specific effects.
While it is clear that δ-catenin is a key regulator of excitatory synapse density and function,
further studies are necessary to resolve the exact nature of its abilities.
Loss of δ-catenin also impairs both spine headwidth and length in hippocampal
neurons [28]. The ability of δ-catenin to modulate spine architecture is mediated by its
ability to link to cadherins and PDZ domain effectors. Knockdown of δ-catenin also impairs
structural plasticity in hippocampal neurons. More specifically, knockdown of δ-catenin
impairs the ability of primary hippocampal neurons to alter spine headwidth in response
to treatment with tetrodotoxin [33]. However, it is still unclear whether overexpression of
δ-catenin affects spine architecture.
The PDZ-binding motif of δ-catenin confers the protein the ability to link to and
functionally influence a variety of synaptic scaffolding proteins. AMPA receptors (AMPAR)
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interact with δ-catenin via scaffolding protein ABP/GRIP to localize to plasma membrane
(Fig. 1) [35]. Overexpression of δ-catenin increases the level of GRIP, surface GluR2 and
ratio of AMPA/NMDA [36]. In contrast, knockdown of δ-catenin leads to decrease of GRIP
and surface GluR2, with no change of the AMPA/NMDA ratio, which may due to the difference of experimental systems [36]. Unlike the effects on the AMPAR, there is no alteration in NMDA receptor response with loss or overexpression of δ-catenin [36]. The ability
of δ-catenin to regulate synaptic density is influenced by its ability to be phosphorylated
by cyclin dependent kinase 5 (CDK5). δ-catenin can be directly phosphorylated at residues S300 and S357 by CDK5 [37]. This phosphorylation promotes its membrane association [37]. A mutant form of δ-catenin expressing S to A mutations at residues 300 and
357, representing constitutively activated forms, enhances the density of dendritic protrusions [37]. Loss of CDK5-mediated phosphorylation of δ-catenin enhances the association between δ-catenin and N-cadherin, GRIP (Glutamate receptor interacting protein) and
PSD95 (postsynaptic density protein 95), resulting in an increase in the surface AMPAR
and ratio of AMPA/NMDA compared to the wild-type δ-catenin [37].
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Figure 1: Schematic of δ-catenin-ABP/GRIP-AMPAR complex.
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δ-catenin also binds to the postsynaptic scaffolding proteins PSD95 and SSCAM
[35,38]. Interestingly, PSD95 and SSCAM also regulate localization of AMPAR to the
plasma membrane [39,40]. Since δ-catenin has a single PDZ-binding motif, it is unclear
what the stoichiometry of PDZ proteins associated with the cadherin-δ-catenin complex is
and how these proteins cooperate to regulate the trafficking and stabilization of AMPAR.
Knockdown of δ-catenin in primary neurons impairs the ability of neurons to promote an increase in the density and length of protrusions in response to stimulation by
DHPG, which promotes activation of the Group 1 mGluR receptors [31]. DHPG stimulation
promotes phosphorylation of δ-catenin at multiple residues, dissociation from PSD95 and
cadherin and increased association with cortactin, suggesting that the abilities of δ-catenin
to regulate spine density in a DHPG-dependent manner may be at least in part due to its
ability to alter links with regulators of the actin cytoskeleton, including cortactin, and cadherin in a phosphorylation-dependent manner [31].
Members of the p120ctn family of proteins are also being recognized as key players in the molecular machinery underlying learning. Chemical long-term potentiation (LTP)
promotes the palmitoylation of δ-catenin by DHHC5 at residue C960-961 located within
the 3rd helix of ARM 8 and this promotes interaction of δ-catenin with cadherin at synapses,
activity-induced stabilization of cadherin at synapses and spine enlargement and insertion
of GluA1 and GluA2 receptors [34]. Further context-dependent fear conditioning in mice
promotes δ-catenin palmitoylation and increased δ-catenin-cadherin associations at hippocampal synapses [34]. Thus, δ-catenin is a critical component of the machinery that
allows coordination of synaptic alterations involved in memory formation.
δ-catenin N-term mice have behavioral deficits, including deficient spatial learning
in water maze and associate learning in fear conditioning [41]. Consistently, these δcatenin mutant mice have abnormal LTP [41].
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Emerging roles for CTNND2 in neurodevelopmental and neurological disorders
Mutations and variations in CTNND2, encoding δ-catenin, have been associated
with several neurological and neurodevelopmental disorders. The cri du chat syndrome is
associated with a cat-like cry, dysmorphic facial features, microcephaly, and intellectual
disability [42]. The syndrome is associated with variable deletions of chromosome 5p resulting in loss of one or more genes from the locus. CTNND2 is localized at 5p15.2 and
the loss of CTNND2 in these individuals correlates with the intellectual disability phenotype
[43]. Additional studies indicate a strong correlation with hemizygosity of CTNND2 and
intellectual disability. An out of frame deletion spanning exons 4-7 of CTNND2 in a human
has been associated with altered facial features and borderline intellectual disability [44].
In addition, two patients with intronic or exonic deletions of CTNND2 have been described
to have intellectual disability [45]. Consistent with the critical role of the gene in intellectual
disability, an individual with the cri du chat syndrome with an additional complex genetic
rearrangement resulting in a partial deletion and partial duplication of CTNND2 has a mild
cognitive phenotype [46,47].
More recent studies suggest a critical role for CTNND2 in the pathology of autism.
Significant excess of missense and copy number variations have been identified in individuals with autism [32]. Interestingly, these variations span the entire protein and are not
restricted to a single domain, suggesting that likely several key functional features of δcatenin are required for its ability to participate in neural circuit wiring crucial to higher
order functions.
Copy number variations in CTNND2 have more recently been identified in cerebral
palsy [48], although the correlation between these variants and the pathology of the disorder remains incompletely characterized. Copy number variations associated with gene
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duplication and disruption of the terminal portion of CTNND2 have been identified in schizophrenia [49]. Recent studies have also implicated CTNND2 in anxiety disorders [50],
although these links need further exploration and validation.
Although δ-catenin has been found in the retina [51], it is still lack of evidence that
δ-catenin also expresses in the lens. Interestingly, genetic variations in CTNND2 have
also been implicated in the development of cortical lens opacities associated with cataract
and cognitive change that precede the development of Alzheimer’s disease [52]. This variant leading to a single amino acid substitution, G810R, in δ-catenin, promotes an increase
in the secretion of Aβ1-42, suggesting a pathological mechanism for a link between this
variation in CTNND2 and the pathology of cataracts and Alzheimer’s disease. It would be
interesting to examine variations in CTNND2 in larger cohorts of Alzheimer’s disease patients to define the extent of contribution of variations in CTNND2 to the pathology of Alzheimer’s disease.
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CHAPTER 1
Materials and methods
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Animals

All experiments were approved by the University of Nebraska Medical Center Institutional Animal Care and Use Committee. Animals were housed in 12/12 dark-light cycle with free access to water and food. δ-catenin N-term mouse was a generous gift from
Dr. Xin Liu (University of California, Los Angeles) [41]. Brain tissue from different regions
and in vitro assay were collected from C57BL/6 mice. For all experiments excepting the
in vitro assay, only male mice were used.

Cell culture and transfection

All cells cultures were incubated at 37 °C with 5% CO2. HEK 293 cell was a generous gift from Dr. Shilpa Buch (University of Nebraska Medical Center). HEK cells were
maintained in DMEM (Thermo Fisher, 11965-092/SH30022.01) supplement with 10%
heat-inactivated FBS (ATLABS) and pen-strep (Thermo Fisher, SV30010). Primary hippocampal and cortical cultures were prepared from E18–19 Sprague-dawley rat (Charles
River Laboratories) as described previously [53] with plating density 18,750 cells/cm2
and 50,000 cells/cm2 respectively. After 4-6 hr after plating, cells were switched to
maintenance medium, containing Neurobasal Medium (Thermo Fisher, 21103049), B-27
Supplement (Thermo Fisher, 17504044) and pen-strep (Thermo Fisher, 15070-063). For
in vitro assay (Fig. 5C), hippocampal culture was treated with mitotic inhibitor 5 µM AraC (Sigma, C1768) at DIV 2-4 to minimize the number of glia cells to specifically test the
cleavage on neurons. Otherwise, gilia were not excluded to mimic the physiological condition in vivo. Half of the media were changed every 3-5 and 2-4 days for hippocampal
and cortical culture respectively.
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Lipofectamine 2000 (Thermo Fisher) was used for transfection according to manufacturer’s protocol. For neurons, plasmids were prepared by EndoFree Plasmid Kit (QIAGEN) and Plasmid Plus Kit (QIAGEN) to minimize endotoxin level. For HEK cells, plasmids prepared by HiSpeed Plasmid Kits (QIAGEN) were also included. All the media
were changed 1 day after transfection for HEK cells and half of the media were changed
4-8 hr after transfection for neurons.

Plasmids
The cDNA construct with the long isoform of mouse δ-catenin (Uniprot identifier:
O35927-1) was a generous gift from Dr. Werner Franke (German Cancer Research
Center, Germany) [9]. The EGFP-δ-catenin constructs carries the short isoform of
mouse δ-catenin (Uniprot identifier: O35927-2) and was a generous gift from Dr.
Shernaz Bamji (University of British Columbia) [34]. The δ-cat shRNA and the shRNAresistant δ-catenin construct basing on the mouse long isoform were described previously [33]. The pSuper GFP vector was used as a control for the δ-cat shRNA. TAP-δcatenin was generated by the Mouse Genome Engineering core facility of University of
Nebraska Medical Center. It carries the long isoform of mouse δ-catenin with its N-terminus fused with a TAP tag: Myc-TEV-linker-His-tag, cloned into the pcDNA3.1 vector.
All the truncated δ-catenin were generated by GeneArt site-directed mutagenesis
system (Thermo Fisher, A13282) with AccuPrime Pfx DNA Polymerase (Thermo Fisher,
12344040) and corresponding primers (Table 1) according to manufacturer’s protocol
using shRNA-resistant δ-catenin cDNA construct as template. It is worth mentioning that
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the DNA sequence encoding ~200-300 aa in δ-catenin has very high GC-content, therefore ≥ 4 % DMSO was included during PCR. All the truncation sites were confirmed by
Sanger sequencing.
Table 1: Primers for truncated δ-catenin.
Construct name

Primers
5’-ATCGTCGTGTCCTCGCCTCTGCCGCCAGCA-3’

DI321440
5’- TGCTGGCGGCAGAGGCGAGGACACGACGAT-3’
5’-ATCGTCGTGTCCTCGTATGAAGACCGTGTC-3’
DI321420
5’-GACACGGTCTTCATACGAGGACACGACGAT-3’
5’- ATCGTCGTGTCCTCGGGCACCTACGCCACC-3’
DI321350
5’-GGTGGCGTAGGTGCCCGAGGACACGACGAT-3’
5’-CTGAGCTCCACCATCGGATCCCGAGCCTCG-3’
DI351390
5’-CGAGGCTCGGGATCCGATGGTGGAGCTCAG-3’
5’-GGCAGCCTGGCAGCTCAGAGCCAGGGGGAT-3’
DI391435
5’-ATCCCCCTGGCTCTGAGCTGCCAGGCTGCC-3’
5’-ACGAGCACAGCCCCGGGCAGCCAACACGGG-3’
DI457468
5’-CCCGTGTTGGCTGCCCGGGGCTGTGCTCGT-3’
5’-TCCTCCCCTGGTGTCGTCCCCTTGCAGCGC-3’
DI462463
5’- GCGCTGCAAGGGGACGACACCAGGGGAGGA-3’
5’- CAGAGCCAGGGGGAT GCCACCTTCCAGAGG-3’
DI441480
5’- CCTCTGGAAGGTGGCATCCCCCTGGCTCTG-3’
5’- GCACATACCGGCACCCCGTCCTCCCCTGGT-3’
DI450455
5’- ACCAGGGGAGGACGGGGTGCCGGTATGTGC-3’
DI421430

5’-CACATAGACCCCATCATGAGGAGTCTCAGC-3’
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5’-GCTGAGACTCCTCATGATGGGGTCTATGTG-3’
5’-TATCAGAAGCCCCCTCGCACGAGCACAGCC-3’
DI431450
5’-GGCTGTGCTCGTGCGAGGGGGCTTCTGATA-3’
5’-CTGAGCTCCACCATCAAGCATTCGCAGGAG-3’
DI351370
5’- CTCCTGCGAATGCTTGATGGTGGAGCTCAG-3’
5’-TCTGAGCAGTACAGCGGATCCCGAGCCTCG-3’
DI371390
5’-CGAGGCTCGGGATCCGCTGTACTGCTCAGA-3’
5’-GGCAGCCTGGCAGCTTATGAAGACCGTGTC-3’
DI391420
5’- GACACGGTCTTCATAAGCTGCCAGGCTGCC-3’

Pharmacological reagents

Pharmacological reagents for neuron treatments were listed below: D-AP5
(Tocris, 0106), (+)-MK 801 (Tocris, 0924), CNQX (Tocris, 1045), ALLN (Sigma, A6185),
MDL28170 (Sigma, M6690), MG132 (Sigma, M7449), tetrodotoxin (Tocris, 1069), lactacystin (Calbiochem, 426100), bafilomycin A1 (Tocris, 1334) and L-NAME (Sigma,
N5751). CA-074 Me was a generous gift from Dr. Huangui Xiong (University of Nebraska
Medical Center). Thapsigargin was a generous gift from Dr. Keshore Bidasee (University
of Nebraska Medical Center). Cortical neurons were treated between DIV10-28. Before
treatment, the volume of the medium was measured to ensure no variability due to evaporation. Control samples were treated with same volume of H2O or DMSO accordingly.
Ca2+-free medium was prepared from Ca2+- and Mg2+-free HBSS (Thermo Fisher,
14170112) supplement with 0.814 mM MgCl2, 10 mM HEPES and extra 24.4 mM D-glucose, then equilibrant with 5% CO2 at 37 °C. Neurons were incubated in Ca2+-free medium for 10-15 min before treatment. CaCl2 (1.8 mM final concentration) were mixed with
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NMDA/vehicle immediately before adding to the cells. The final concentrations of Mg2+
and Ca2+ were identical to the maintenance medium. For KCl treatment, extra 55 mM
KCl was added to the maintenance medium for a final concentration of 60.33 mM.

Lysate preparation and immunoblotting

For brain tissue collection, animal was anaesthetized by isoflurane and the brain
was dissected in cold 1XPBS on ice. Brain tissues were quick frozen on dry ice and storied at -80 °C. Since δ-catenin in the brain tissue is susceptible to cleavage during the
freeze-thaw cycle (data not shown), cold lysis buffer was added before thawing the tissue on the ice. 100-1000 µL cold lysis buffer was used depending on the size of the tissue. Lysis buffer includes 1:100 proteinase inhibitor (Sigma, P8340), 1:100 phosphatase
inhibitor (Sigma, P0044) in the RIPA buffer (50 mM Tris pH7.4, 107 mM NaCl, 1% Triton
X-100, 0.1% SDS). Besides the in vitro assay, all lysis buffer include 5 mM EDTA and an
extra 5 mM EGTA for neuron or tissue. Brain tissues were homogenized for 2 s on ice by
sonicator (22-25% amplitude) for 3-8 times depending on the size of the tissue, with minimally 60 s interval between rounds.
Before neuron lysis, cells were washed with cold 1XPBS. HEK cells were lysed
without wash since they tend to detach. 70-100 µL cold lysis buffer was added per well
in a 6 well plate. After being scraped off by a cold cell scraper, cells were first pipetted
up and down for about 30 times, then sheered with a cold 26/27G needle for about 30
times. All the procedures were done on ice.
All the lysates were centrifuged 15,000 rpm for 15 min at 4 °C, then quick frozen
on dry ice and storied at -80 °C. Supernatants were mixed with laemmli buffer and
loaded on the gel (30-50 µg/well). For DcatCTI/II detection in neural lysate, 50 µg/well

16
was optimal. Both hand-casted and precasted gels (BioRad, 456-1084 and 456-1024)
were used for SDS-PAGE. To separate DcatCTI/II, 7.5-8% gels were used. For separating DcatCTI and II from neural lysate, we had to run the gels longer making β-tubulin unusable as a house keeping marker. In such case, we used Na+/K+-ATPase as a loading
control.
Dilution of antibodies for immunoblot were listed below: 1:900 TL (BD Biosciences, 611537), 1:50 J19 (Progen, 651152), 1:100-1:500 β-tubulin (DHSB, E7), 1:200
actin (DHSB, JLA20), 1:400 Na+/K+-ATPase (DHSB, a6F), 1: 5000 N-cadherin (BD Biosciences, 610920); 1: 1000 PSD95 (Millipore, MAB1598); 1:2000 CaMKIIɒ (Millipore,
6G905-532); 1:1000 GAPDH (Thermo, PA1-988); 1: 4000 ɒII-spectrin (clone AA6, Enzo,
BML-FG6090), 1:16000 HRP-conjugated anti-rabbit IgG (Jackson ImmunoResearch,
711-035-152) and 1:16000 HRP-conjugated anti-mouse IgG (Jackson ImmunoResearch, 711-035-151). 587 is a custom-made polyclonal rabbit antibody from
Thermo Fisher. It targets SELNYETSHYPASPDSWV of δ-catenin and was purified with
GST fusion protein. Myc antibody (clone 9E10) was produced by the core facility of University of Nebraska Medical Center. ARVCF antibody was a generous gift from Dr. Keith
Johnson (University of Nebraska Medical Center).
Blots were detected by SuperSignal West Dura chemiluminescent substrate
(Thermo Fisher, 34076) and imaged by FluorChem HD2 (Cell Biosciences). All the blots
were quantified by AlphaView (ProteinSimple) or ImageJ. Sum signal of each band/isoform was subtracted by the sum background signal of the similar sized selection area.
All the protein quantifications were normalized to a housekeeping protein shown in the
blot.
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In vitro cleavage assay

As described earlier, the in vitro assay is identical to the lysate preparation except exclusion of chelator in the lysis buffer. For inhibitor testing (Fig. 6C), inhibitor or
vesicle was mixed with lysis buffer immediately before adding to the cells. However,
since CA-074 Me needs to be hydrolyzed by intracellular enzyme for irreversible inhibition of cathepsin B, cells were pretreated with CA-074 Me instead of directly mixing the
inhibitor with lysis buffer.

Calculate molecular weight

The molecular weight measurement was done in AlphaView and refers to protein
ladders from BioRad (1610394/1610393). Only lanes right next to the protein ladder
were used for measuring molecular weight to ensure accuracy. Molecular weight for
DcatNT and DcatCT were measured on blots probing with J19 and 587 respectively.
Due to the band of DcatNTII being thick, the molecular weight of DcatNTII was represented by the higher boarder of band.
The molecular weight of DcatCTII from both NMDA- and glutamate-treated samples were pooled to represent DcatCTII in neuron. Moreover, since the sample beside
the ladder was always control, often having only DcatI (DcatICtrl), we thus calculated
DcatII as below:
DcatII = DcatCTICtrl − (DcatCTINMDA/Glut − DcatCTIINMDA/Glut )
DcatCTINMDA/Glut and DcatCTIINMDA/Glut are the DcatCTI and CTII from the NMDA- or glutamate-treated samples respectively.
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δ-catenin purification
TAP- δ-catenin in HEK cells were purified by PureProteom magnetic protein A/G
beads (Millipore, LSKMAGA02/LSKMAGG02) according to the manufacturer’s protocol
with some modifications. The beads were cross-linked to Myc antibody then blocked with
5% BSA. The fresh lysate was incubated with the beads on a rotator at 4 °C overnight.
After washing with lysis buffer (a different protease inhibitor was used: Thermo Fisher
88266), the TAP- δ-catenin were eluted with glycine (pH 2.5). Elution was immediately
neutralized by Tris buffer (pH 8.0) and then stored at -80 °C. Independent batch of purified δ-catenin was used for each independent experiment.
For in vitro cleavage using purified δ-catenin, fresh lysate was prepared from
non-transfected HEK cells and mixed with purified δ-catenin at 4 °C for 1 hr. The reaction was stopped by adding laemmli buffer to the samples. For heat inactivation, lysate
was incubated at 80 °C for 10 min before the reaction.

Immunocytochemistry and microscopy

Briefly, coverslips were fixed in warm (37 °C) fixation buffer with 4% PFA and 4%
sucrose in 1XPBS for 20 min. 10 min of 0.1% Triton X-100 was used for permeabilization. Images were taken by LSM 700 confocal microscope (Zeiss) with 2048 × 2048 dpi,
8 bit, Zoom 2, speed 6, 9 stacks with 0.47 µm interval. The expression of full-length or
calpain-resistant δ-catenin in knockdown neurons were confirmed by immunostaining
with δ-catenin. Dendritic protrusions from the thickest dendrite from each neuron was
measured. All the protrusions located more than 10 μm from the soma were manually
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analyzed in Z-stack in ImageJ. All the analyses were done blind to the experimental
groups.

Statistics

Statistics tests were performed in Prism 7 (GraphPad) and MATLAB. D'Agostino
and Pearson normality test were performed for all the data and parametric/nonparametric test was performed accordingly. Data with too few number for the normality test was
treated as normal distributed. n represents the number of independent experiments. CI
was calculated as 95% confidence interval. Two-tailed p-value was calculated accordingly and significance level was 0.05. 0.05 ≤ p < 0.01: indicated by number in each
panel; p ≤ 0.01: **; p ≤ 0.001: ***; p ≤ 0.0001: ****.

Immunoblot and morphology analysis
Quantification for different brain region (Fig. 2B) were first normalized to βtubulin, then normalized to the average DcatCT or NT level of five brain regions in the
same mouse to reduce the data to independent observations [54].
For analysis of pharmacological treatments, the treatment groups were paired to
the control sample of the experiment. Moreover, the effect of treatment was measured
by ratio instead of difference, compared to the control; thus, the results were log transformed before statistical analysis.
For analysis of MK801 and CNQX treatment (Fig. 11B-D), due to the null hypothesis is ‘the treatment affects the level of DcatCT/NT/SBDP, thus, correction for false positive is not applicable in this case. For repeated measure two-way ANOVA, data were
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presented by mean ± CI to accurately represent the relationship of data across groups in
different tests.
For morphology analysis, all the data points were normalized to the geometric
mean/median of the vector group of the experiment so that unpaired tested could be performed. Since the data were nonparametric distributed and rank-based test would be
performed, thus they were not transformed to logarithmic scale.

Fraction and approximate density for each population
Because not all the protrusions were measured for width and length due to some
of the protrusions overlaping with each other, fraction for each population in each dendrite was calculated from the total number of Pn protrusion measured:

Pn fraction =

Number of Pn
Number of (P1 + P2 + P3 )

n = 1, 2, 3.
Approximate density was used to represent the density for the population.
Approximate Pn density = Pn fraction × Protrusion density
Due to a few dendrites in the vector group having no protrusion from certain population, Pn fraction or approximate density was normalized to the median of the vector
group in each experiment.
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Determine P1 density threshold
Probability frequency was estimated by Kernel smoothing function. To better visualize the distribution of the data, estimation was calculated by bootstraping with replacement for 500 times. The threshold was drawn according to the distribution difference basing on the criteria mentioned in the text.

Above threshold fraction comparison
Above threshold fraction for each group was calculated from bootstrap with replacement for 5,000 times. The difference between each group and the knockdown sample, (each group - δ-cat shRNA), in each resampling was calculated and the p-value was
equal to the number of (difference ≥ 0) divided by 5,000. The stack of five p-value were
then corrected by Bonferroni-Dunn correction.
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CHAPTER 2
DcatCT and NT are two novel forms of δ-catenin
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Two novel isoforms of δ-catenin in the brain
We generated a rabbit polyclonal antibody to δ-catenin (587) using an epitope
targeting the C-terminal (Fig. 2A). We validated the specificity of this antibody and two
other commercial antibodies (TL and J19) using striatal lysates from wild-type, homozygous and heterozygous δ-catenin N-term mice [41]. As previously described [41], δcatenin N-term mice include only the N-terminal region of δ-catenin up to 461 aa (Fig.
2A). Both the TL and J19 antibodies detected the truncated form of δ-catenin predicted
in the δ-catenin N-term mice (Fig. 2B), while the C-terminal 587 antibody did not detect
either full-length or N-term protein in the δ-catenin N-term mice consistent with the lack
of the C-terminal region in these mice. These data confirm the specificity of the antibodies.
In addition to the full-length δ-catenin forms, we observed two bands with molecular weights of 47.67 ± 0.5774 and 40.67± 0.5774 kDa (n = 3, mean ± SD) detected by
the TL and J19 antibodies, but not the 587 antibody (Fig. 2B), indicating that they include
the N-terminal region of the protein, but not the C-terminal. These proteins are collectively referred to as DcatNT for δ-catenin N-terminus. Similarly, we observed a ~90 kDa
band that could be detected by the C-terminal 587 antibody, but not the N-terminal TL
and J19 antibodies (Fig. 2B). This band is referred to as DcatCT for δ-catenin C-terminus.
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Figure 2: The expression of two novel forms of δ-catenin, DcatNT and DcatCT,
in the brain.
(A) Schematic of protein structures of δ-catenin and the truncated δ-catenin in the δcatenin N-term mouse model. Epitopes of δ-catenin antibodies: TL, J19 and 587, are
indicated by blacklines. (B) Immunoblot for δ-catenin in striatum from wild-type (WT),
heterozygous (Het) and homozygous (Homo) mice. Lysates were probed with δcatenin antibodies, 587 (left), TL (middle) and J19 (right) as indicated. The top two
sections in each panel are from the same blot. The first section is either a long exposure (LE) or dark adjusted (Dark) version for better visualize the protein with low expression. The second section is either a short exposure (SE) or light adjusted (Light)
version for better visualized the protein with high expression. * Non-specific band. For
each genotype, n ≥ 3 animals were tested for each antibody.
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We further characterized the expression pattern of DcatNT and DcatCT in different brain regions. Expression of DcatNT was relatively similar in the olfactory bulb, hippocampus, cortex, cerebellum and striatum as detected by both TL and J19 antibodies
(Fig. 3A-B). In contrast, expression of DcatCT varied in different regions with lower levels in the olfactory bulb and cerebellum compared to the hippocampus, cortex and striatum (Fig. 3A-B). These data indicate that multiple forms of δ-catenin that include either
the N- or C-terminus are differentially expressed in different regions of the brain.
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Figure 3: The expression of DcatNT and CT in different brain regions.
(A) Immunoblot for δ-catenin and (B) quantification of DcatCT and NT in different
brain regions in 1-2 months old mice (n = 3, mean ± SD).
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DcatCT and NT are generated via a calpain-dependent mechanism

We sought to examine the mechanisms by which DcatCT/NT are generated. We
examined if the two forms of δ-catenin could be generated in transiently transfected HEK
cells by transfecting full-length δ-catenin cDNA and immunoblot analysis (Fig.
4A). These lysates were prepared in EDTA-free buffers as indicated in the methods.
Both the DcatCT and NT fragments could be detected in these lysates. Similar results
were observed with a shorter isoform of δ-catenin (Fig. 4B). Thus, the machinery for
generating DcatCT and NT exists in HEK cells. We took advantage of this system to examine the requirements for generation of DcatCT and NT. Since several proteases can
cleave their substrates in a divalent ion-dependent manner that can be blocked by metal
chelators, we examined if the generation of DcatCT in HEKs was dependent on chelator.
HEK cells were transfected with cDNA for δ-catenin and lysed in buffers containing different levels of EDTA and the level of DcatCT was examined by immunoblot analysis
(Fig. 5A). With increasing concentration of EDTA, the levels of DcatCT were reduced, indicating the sensitivity of DcatCT generation on a divalent ion. To establish the identity of
the divalent ion, we performed similar experiments in lysates substituted with Ca2+, Mg2+
or Zn2+. As shown in Fig. 5A, the inclusion of Ca2+ was sufficient to restore generation of
DcatCT. These data indicate that the generation of DcatCT is dependent on Ca2+.
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Figure 4: The generation of DcatCT and N-terminal fragments can be recapitulated in lysates from δ-catenin-transfected HEK cells.
Immunoblot for DcatCT and N-terminal fragments in an in vitro cleavage assay on
HEK cells transfected with (A) δ-catenin cDNA plus vector or δ-cat shRNA (n = 4), (B)
EGFP-tagged δ-catenin short form (n = 3).
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To confirm that these data are relevant to neurons, we examined the chelator-dependence for generation of DcatCT and NT in neurons with and without chelator in the
lysis buffer. Hippocampal tissue or primary rat cortical were lysis in a buffer with or without chelator and immunoblotted to detect DcatCT or NT. Similar to the results observed
in HEK cells, the levels of DcatCT and NT were dependent on the chelator (Fig. 5B-C).

Since several proteases are Ca2+-dependent, we examined if DcatCT and NT
could be generated by cleavage by a Ca2+-dependent protease. We purified TAP-tagged
δ-catenin from transiently transfected HEK cells and examined the ability of this protein
to be cleaved by lysate from un-transfected HEK cells. Purified δ-catenin was incubated
with increasing amounts of lysates from un-transfected HEK cells and the generation of
DcatCT examined by immunoblots (Fig. 6A). The generation of DcatCT showed a dosedependence on the amount of lysate from un-transfected HEK cells. The generation of
DcatCT were abolished when the purified δ-catenin was incubated with heat-inactivated
HEK lysates (Fig. 6B). These results suggest that δ-catenin is cleaved to generate
DcatCT by a Ca2+-dependent protease that is ubiquitously expressed.

One candidate protease for Ca2+-dependent cleavage is calpain, a Ca2+-dependent cysteine protease with known roles in proteolysis in stroke, Alzheimer disease and
Parkinson disease [55]. We took advantage of known inhibitors of calpain to examine if
DcatCT and NT were generated by calpain-mediated cleavage of δ-catenin. Primary
neurons were lysed in lysis buffer that included chelators and either ALLN, MDL28170
and MG132 and immunoblotted to detect DcatCT. As a positive control we also included
lysates without chelators (Fig. 6C). In lysates with either of the inhibitors, the levels of
DcatCT were significantly decreased in comparison to lysates without chelators, suggesting that DcatCT may be generated in a calpain-dependent manner in neurons. Since
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ALLN and MG132 are also proteasome inhibitors [56], we confirmed that these effects
were not mediated by the proteasome by using a proteasome inhibitor lactacystin in the
same assay (Fig. 6C). Since all three inhibitors also inhibit lysosomal protease cathepsin
B [56], we also examined if a cathepsin B inhibitor would have similar effects (Fig. 6D).
The cathepsin B inhibitor, CA-074 Me, did not alter the levels of DcatCT and NT. These
results indicate that DcatCT and NT are generated in a calpain-dependent manner in
HEKs and neurons.
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Figure 5: The generation of DcatCT and NT is chelator-dependent in an in vitro
cleavage assay.
(A) Immunoblot for DcatCT in lysates of δ-catenin-transfected HEK cells in indicated
buffers with indicated dose of chelator and chelator supplemented with divalent ions
(n = 3-4). Immunoblot for DcatCT and NT in lysates of (B) P1-3 hippocampal tissue (n
= 4) and (C) primary hippocampal culture (DIV 20-21, n = 3) with/without chelators.
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Figure 6: The generation of DcatCT and NT is mediated by calpain in an in vitro
cleavage assay.
Immunoblot for (A) DcatCT in purified full length δ-catenin (TAP-δ-catenin) mixed with
indicated dose of HEK cell lysate (n = 3); (B) DcatCT from purified full length δcatenin mixed with control or heat-inactivated non-transfected HEK cell lysate (n = 3);
(C) DcatCT in an in vitro cleavage assay on cortical neurons supplemented with calpain and proteasome inhibitors (ALLN: 50 μM; MDL28170: 100 μM; MG132: 50 μM;
lactacystin: 20 μM; n = 3-4); (D) DcatCT and NT in an in vitro cleavage assay on cortical neurons pretreated with 5 μM CA-074 Me for 15 min before lysis (n = 3).
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CHAPTER 3
DcatCT and NT can be generated by two independent
mechanisms
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DcatCT and NT can be generated in an NMDAR-dependent manner by calpain
cleavage
δ-catenin is localized at synapses and regulates synaptic structure and function
[57] and calpain can be activated via glutamate receptor activation [55]. We examined if
the ability of δ-catenin to be cleaved by calpain can be induced by glutamate receptor
activation. Primary cortical neurons in culture were treated with 20 μM glutamate for 5
min. After treatment, neurons were lysed in a buffer containing chelators to avoid confounds from calpain-mediated cleavage occurring during the processing of the neurons
and the levels of DcatCT and NT were examined by immunoblot analysis (Fig. 7A). The
levels of DcatCT and NT increased with glutamate treatment indicating that they were
regulated by glutamate receptor activation. To examine if these effects were mediated
by NMDA receptors (NMDAR), similar experiments were performed in the presence of
two NMDAR inhibitors, D-AP5 and MK801. Treatment with these inhibitors significantly
reduced the levels of DcatCT and NT induced by glutamate treatment (Fig. 7A), indicating that NMDAR activation-mediated cleavage of δ-catenin. To further confirm that this
cleavage was calpain-dependent, we performed similar experiments in the presence of
two calpain inhibitors, ALLN and MDL28170. The presence of the calpain inhibitors significantly blocked the cleavage of δ-catenin mediated by glutamate (Fig. 7A). Since
ALLN and MDL28170 also inhibit cathepsin B, to confirm that these effects were indeed
mediated by calpain, we performed similar experiments in the presence of the cathepsin
B inhibitor CA-074 Me (CA). This inhibitor was unable to block glutamate induced cleavage of δ-catenin (Fig. 7B). These results indicate that δ-catenin can be cleaved in an
NMDAR-dependent manner by calpain to generate DcatCT and NT.
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Figure 7: Glutamate induces NMDAR- and calpain-dependent generation of
DcatCT and NT.
Immunoblot for DcatCT and NT in cortical neurons treated with 20 μM glutamate for 5
min with 10 min pretreatments with (A) NMDAR or calpain inhibitors (ED- Ctrl: control
sample lysed without chelator; D-AP5: 100 µM, MK 801: 10 µM, ALLN: 50 µM and
MDL28170: 100 µM, n = 3), or (B) cathepsin B inhibitor (CA-074 Me: 5 μM, n = 3).
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We further characterized the glutamate receptor dependence of δ-catenin cleavage by calpain. Using a similar strategy as above, we confirmed that the cleavage of δcatenin is mediated by NMDAR, by using NMDA instead of glutamate (Fig. 8A-B). Similar to the results obtained for the glutamate-induced cleavage studies described above,
our data indicate that the cleavage of δ-catenin is dependent on NMDAR and can be inhibited by calpain inhibitors (Fig. 8C-D). The NMDAR and calpain-mediated cleavage of
δ-catenin was unaffected by tetrodotoxin (TTX), a voltage-dependent sodium channel
blocker, Nimodipine, a L-type voltage-dependent calcium channel (VGCC) blocker, ascomycin, an inhibitor for the Ca2+-dependent phosphatase calcineurin, and lactacystin.
To further examine the requirement for Ca2+-influx in the ability of δ-catenin to be
cleaved, primary neurons were treated with NMDA in Ca2+-free extracellular media and
processed as above. The levels of DcatCT and NT were significantly reduced in the
samples treated with NMDA in Ca2+-free extracellular media in comparison to media
containing Ca2+ (Fig. 8E). These studies indicate that the calpain-mediated cleavage of
δ-catenin is mediated by NMDAR and requires Ca2+-influx through the NMDAR.
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Figure 8: NMDA induces Ca2+-influx and calpain-mediated cleavage of δcatenin.
Immunoblot for (A) DcatCT in cortical neurons treated with indicated dose of
NMDA/glutamate for 5 min (n = 3); (B) DcatCT in cortical neurons treated with 100
µM NMDA for indicated lengths of time (n = 3); (C) DcatCT and NT in cortical neurons
treated with 100 µM NMDA for 5 min with pretreatments with NMDAR inhibitors or (D)
calpain inhibitors (10 min pretreatment: TTX: 1 µM, lactacystin: 20 µM, nimodipine
(Nimo): 10 µM, ascomycine (Asco): 2 µM, n = 3-4); (E) DcatCT and NT in cortical
neurons treated with 100 µM NMDA for 5 min in extracellular medium with/without
Ca2+ (n = 3).
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The basal generation of DcatCT and NT is NMDAR-independent

On closer examination, we observed that the DcatCT included two separate
bands (I and II), appearing as a duplex. We further characterized these forms using primary neurons and immunoblot analysis (Fig. 9A). DcatCTI and II are very close in molecular weight, 97.13 ± 0.8345 and 89.63 ± 1.302 kDa respectively (n = 8, mean ± SD).
As shown in Fig. 2B, there are two forms of DcatNT that differ in molecular weight of
about 7 kDa. These data suggest that there are two calpain sites within δ-catenin that
are in close proximity to each other. Consistently, Pearson correlation test showed that
DcatCTI/II and DcatNTII/I were correlated (Fig. 9B). Further, while DcatCTI is the predominant form under basal conditions, the generation of DcatCTII is more sensitive to
activity (Fig. 9A). There is a significant decrease in the ratio of DcatCTI to II (DcatCTI/II)
and DcatNTII to I (DcatNTII/I) with glutamate treatment (Fig. 9C-D). Taken together,
these data indicate that there are likely two sites of calpain cleavage on δ-catenin that
differ in sensitivity to activity mediated by NMDAR activation.

39

A

B

C

D

Figure 9: DcatCT consists of two forms, DcatCTI and II.
(A) Immunoblot for two forms of DcatCT and NT, DcatCTI, CTII, NTI and NTII, in cortical neurons treated with NMDA/glutamate for 5 min (NMDA: 50 µM, glutamate: 20
µM). (B) Pearson correlation of the ratio of DcatCTI/II and DcatNTII/I. These data are
pooled from replicates of the data shown in (A) and Fig. 7B, control (n = 10), NMDA
(n = 7) and glutamate (n = 6). (C-D) Quantification of DcatCTI/II and DcatNTII/I in the
glutamate treated samples in (B) (paired t-test with Bonferroni-Dunn correction; mean
± SD).
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Our data demonstrate that DcatCT is sensitive to cleavage upon NMDA stimulation (Fig. 8), suggesting that the basal level of DcatCTI is generated by basal neural activity and inhibition of NMDAR would block the generation of DcatCTI. However, blocking
neural activity by TTX did not affect the levels of DcatCT and NT (Fig. 10A-C). Consistent with a lack of calpain activation under these conditions, there was no difference in
the levels of SBDP (spectrin breakdown product) with TTX (Fig. 10D). SBDP is a commonly used marker whose cleavage is regulated by calpain [55]. These results are surprising, considering that the NMDAR is expected to be suppressed under these conditions. One possibility is that the mEPSCs are sufficient to induce basal cleavage of δcatenin. To evaluate this, primary neurons were treated with MK801. Under these conditions, there were no changes in the levels of DcatCT and NT (Fig. 11A-C). Similarly,
treatment of neurons with the AMPAR inhibitor CNQX, or even CNQX and MK801 cotreatment, had no effect on the levels of DcatCT, NT and SBDP (Fig. 11A-D).

The basal levels of DcatCT and NT could also be affected by degradation of the
protein in an NMDAR-dependent manner. To examine if the degradation of δ-catenin
mediated by a proteasome-dependent pathway may explain these results, we similarly
evaluated the effects of lactacystin-mediated inhibition of proteasome-mediated degradation on the levels of DcatCT and NT. Lactacystin treatment significantly increased the
level of DcatNT and SBDP, but not CT (Fig. 11F-H), indicating that DcatNT and SBDP
are degraded by proteasome (Fig. 11E). Co-treatment of lactacystin and MK801 does
not significantly alter the levels of DcatNT and SBDP compared to lactacystin control
(Fig. 11E-H), indicating the basal δ-catenin cleavage is NMDAR-independent. Consistently no differences in the levels of DcatCT or NT were observed with D-AP5 treatment
(D-AP5: 50 µM for 3 hr; paired t-test, DcatCT: p = 0.5767, DcatNT: p = 0.2190; SBDP: p
= 0.0912; n = 4).

41

A

B

C

D

Figure 10: Inhibition of neural activity has no effect on the basal level of DcatCT
and NT.
(A) Immunoblot and (B-D) quantification of DcatCT, NT and SBDP in cortical neurons
treated with TTX for 3 hr (TTX: 1 µM; paired t-test; DcatCT: p = 0.0982, n = 6;
DcatNT: p = 0.8696, n=7; SBDP: p = 0.1991, n = 5; mean ± SD).
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Figure 11: Inhibition of NMDAR has no effect on the basal level of DcatCT and
NT.
(A) Immunoblot for DcatCT, NT and SBDP in cortical neurons treated with 3 hr inhibitors of NMDAR, AMPAR and proteasome (MK801: 10 µM, CNQX: 10 µM, Lact: 10
µM). (C-D) Quantification from samples with NMDAR and AMPAR inhibitors (paired ttest, n = 4, mean ± SD). (E) Diagram of predicted changes on the levels of
DcatCT/NT/SBDP based on generation and degradation. (F-H) Quantification from
samples with proteasome inhibitor (paired t-test: Ctrl vs. Lact, n = 4; Lact vs. Lact+
MK, n = 3).
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Besides NMDAR, another major source for intracellular Ca2+ in neuron is VGCC.
We evaluated the sensitivity of the basal pool of DcatCT and NT to the L-type VGCC
blocker, nimodipine. While nimodipine treatment significantly increase the level of SBDP,
indicating that under these conditions calpain was activated, this treatment had no effect
on the basal levels of DcatCT or NT (Fig. 12).

These data indicate that there is a basal pool of DcatCT and NT that are very
similar in size to the CT and NT forms generated by NMDAR-mediated calpain cleavage
of δ-catenin. This pool is resistant to alterations by spontaneous neural activity mediated
by NMDAR or AMPAR. Further, this pool is also unaltered by Ca2+-influx via L-type
VGCC. However, DcatNT from this pool is degraded in a proteasome-dependent manner. Taken together, these data indicate that (1) there is a basal pool of DcatCT and NT
that is likely generated in an NMDAR-independent manner, (2) DcatCT and NT from this
pool is likely differentially regulated since only the NT, but not the CT is degraded via a
proteasome-dependent mechanism.
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Figure 12: Inhibition of L-type VGCC has no effect on the basal level of DcatCT
and NT.
(A) Immunoblot and (B-D) quantification of DcatCT, NT and SBDP in cortical neurons
treated with 3 hr L-type VGCC inhibitor (Nimo: 10 µM; paired t-test; DcatCT: p =
0.1410; DcatNT: p = 0.1408; n = 7; mean ± SD).
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Lysosomes constitute another major protein degradation pathway in neurons. To
examine if DcatCT is degraded via a lysosome-dependent pathway, we took advantage
of a V-ATPase inhibitor, bafiloymince A1 (Baf). To test this, primary neurons were incubated with Baf for 3 hr. Under these conditions, it is expected that the Baf will alter the
lysosomal pH thus inhibiting its function [58]. Baf treatment did not affect the levels of
DcatCT, but significantly reduced the levels of NT (Fig. 13A-C). These results could be
explained by a model in which both cleavage of full-length δ-catenin and degradation of
DcatCT are both regulated by the lysosome (Fig. 11E).
To confirm that Baf treatment effects on δ-catenin are not a secondary consequence of cell stress and cell death, we examined the levels of SBDP (Fig. 13D) and observed no significant differences in the levels of this product in control or Baf-treated
neurons. To further confirm that these results are not a secondary consequence of ER
stress in neurons under Baf-treated conditions, we examined the levels of DcatCT and
NT in neurons treated with thapsigargin (Thap) for 3 hrs. Under these conditions, Thap is
expected to induce ER stress [59] and DcatCT or NT as well as SBDP were not significantly altered (Fig. 13A-D). These data indicate that generation and degradation of
DcatCT under basal conditions is regulated by the lysosome while only the generation
but not degradation of DcatNT is regulated by the lysosome.

Further, treatment of primary unstimulated neurons with MDL28170 altered the
levels of DcatCT and NT in a manner similar to the results obtained with Baf, in which
the levels of DcatCT was unaltered by treatment but the levels of NT was significantly reduced (Fig. 13A-C). MDL28170 inhibits the classic calpains and cathepsin B but there is
less support to indicate that it effective inhibits atypical calpains [60,61]. Under these
conditions, SBDP was also not altered in levels (Fig. 13D), indicating that under basal
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conditions, the typical calpains are not activated and it is uncertain whether the basal
generation SBDP is mediated by atypical calpain. The decreased levels of DcatNT under
these conditions in consistent with a model in which MDL28170 inhibits cathepsin B,
which in turn disrupts lysosome function thus decreasing δ-catenin cleavage. To confirm
these results, primary neurons were treated with CA-074 Me. This treatment caused a
significant decrease of DcatNT but not change of CT or SBDP (Fig. 14). Thus, the inhibition of cathepsin B is sufficient to inhibit the basal generation of DcatCT and NT. These
results, taken together with the data above, suggest that DcatCT and NT exist in multiple
forms. A fraction of the DcatCT and NT are generated in an NMDAR-dependent manner
by typical calpain-mediated cleavage. Another fraction is likely not cleaved by the typical
calpains, but is generated in a lysosome-dependent manner.
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Figure 13: Disrupt the normal function of lysosome decreases the basal level of
DcatNT, but not CT.
(A) Immunoblot and (B-D) quantification of DcatCT, NT and SBDP in cortical neurons
treated with 3 hr bafilomycin A1 (Baf), thapsigargin (Thap) and MDL28170 (Thap: 200
nM, Baf: nM, MDL: µM; paired t-test with Bonferroni-Dunn’s correction, n = 4-5, mean
± SD).
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Figure 14: Inhibition of cathepsin B decreases the basal level of DcatNT, but not
CT.
(A) Immunoblot and (B-D) quantification of DcatCT, NT and SBDP in cortical neurons
treated with 3 hr cathepsin B inhibitor (CA-074 Me: 1 µM; paired t-test, n = 4, mean ±
SD).
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To assess if the basal cleavage and NMDAR-dependent cleavage of δ-catenin
are correlated, we examined the levels of DcatCT and NT in neurons treated with
NMDA/KCl after 3 hr Baf treatment (Fig.14A). Baf had no effect on NMDAR-induced
cleavage of δ-catenin and ɒII-spectrin (Fig. 15B-D), indicating that the basal and
NMDAR-mediated cleavage of δ-catenin are two independent pathways. Interestingly,
with depletion of synaptic vesicle by Baf, KCl still managed to induce δ-catenin cleavage,
but not able to reduce DcatI/II and NTII/I (Fig. 15B-C, 15E-F). It is unclear whether the
KCl-induced δ-catenin cleavage is generated by VGCC activation, or NMDAR activation
by synaptic vesicles belong to a reserve/inactive pool. Moreover, NMDA induced decrease of DcatCTI/II and NTII/I were significantly lower compared to KCl (paired t-test,
both p-value < 0.01, n = 4). These results are consistent with the previous observation
that NMDAR activation preferably cleaves δ-catenin at the second cleavage site (Fig.
9C-D).

Taken together, these data indicate that (1) there are multiple forms of DcatCT
and NT; (2) some of the DcatCT and NT forms are generated in an NMDAR-dependent
manner by cleavage of δ-catenin by calpain; (3) some of the DcatCT and NT forms are
generated in a lysosome-dependent and NMDA-independent manner; (4) DcatCT and
NT are degraded by independent mechanisms.
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Figure 15: The basal and NMDAR-dependent forms of DcatCT/NT are generated
in two independent pathways.
(A) Immunoblot and (B-D) quantification of DcatCT, NT and SBDP, (E-F) DcatCTI/II
and DcatNTII/I, in cortical neurons treated with 5 min NMDA/KCl after 3 hr Baf pretreatment (Baf: 50 nM, NMDA: 50 µM for 5 min, KCl: extra 55 mM for 5 min; repeated
measure two-way ANOVA, Dunnett's multiple comparisons test to the control samples of both groups, n = 4, mean ± CI).
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CHAPTER 4
The functional role of δ-catenin cleavage in dendritic
protrusion development
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Mapping the calpain cleavage sites on δ-catenin
As described above, the calpain cleavage in δ-catenin can be recapitulated in
HEK cells, since the molecular weights of the DcatCT generated in HEK cells are similar
in size to those generated in neurons (Fig. 16A-B). Thus, we decided to take advantage
of the cleavage assay in HEK cells to map the sites of calpain cleavage in δ-catenin.
Based on antibody epitope recognition site of the J19 antibody (392-309 aa) and its ability to recognize the DcatNT (Fig. 2B), we reasoned that the cleavage site of calpain in δcatenin was located in the region C-terminal to this epitope region. Further, the δ-catenin
N-term mice express a fragment of δ-catenin up to 461 aa. Our data indicate that this
form can be cleaved by calpain (Fig. 2B). This led us to hypothesize that the site of
cleavage is located within 310-460 aa. We generated several constructs of δ-catenin
that included various deletions in this region, as shown in Fig. 16C. These constructs
were transiently transfected in HEK cells, lysates prepared and the expression of
DcatCT were detected by immunoblot analysis (Fig. 16D). For these studies, lysates
were prepared in buffers lacking chelator to allow for sufficient calpain activation.

Using this assay, our data (Fig. 16D) indicate that a construct that includes a deletion in δ-catenin spanning amino acids 321-440 (DI321440) is significantly resistant to
cleavage. A construct that includes a deletion in aa 321-420 (DI321420) allows generation of DcatCTII, but not DcatCTI. Further, deletion of aa 351-390, but not aa 321-350,
significantly blocks generation of DcatCTI. Taken together, these results indicate that the
cleavage site that allows for generation of DcatCTI is within the region that includes aa
351-390.
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We also note that while constructs that include deletions in aa 351-370
(DI351370) and aa 371-390 (DI371390) decrease the levels of DcatCTI that are generated in comparison to the full-length δ-catenin, the constructs are not completely resistant to cleavage. Similar results were observed in case of DcatCTII with constructs
that included deletions of aa 420-430 (DI420430) and aa 431-450 (DI431450). If the second calpain cleavage site exists within the region of aa 420-440, one would predict that
construct that included deletions in this region (Dl391435, aa 391-435) would be resistant to cleavage that would allow generation of DcatCTII. However, we do observe
some cleavage in constructs expressing these deletions. The deletion generated in the
constructs would lead to a shorter form of the protein. Since the deleted form still has the
cleavage site for DcatCTI, we may be unable to specifically identify DcatCTII in these lysates based on size. However, the 391-435 construct is more resistant to cleavage than
full-length δ-catenin. Taken together, these data indicate that the regions between aa
351-390 and 390-440 are likely cleaved by calpain to generate DcatCTI and II respectively.

54

A

B

C

D

Figure 16: Mapping the calpain cleavage sites on δ-catenin by in vitro cleavage
assay.
(A) The immunoblot represents an overlay of single blot adjusted to two different intensities to illustrate molecular weights of DcatCTI/II from in vitro cleavage assay and
glutamate treatment on cortical neurons (red: light adjustment, black: dark adjustment, n = 4). (B) Quantification of molecular weights of DcatCTI and II generated from
in vitro cleavage assay on δ-catenin-transfected HEK cell and glutamate/NMDA
treated cortical neurons (two way-ANOVA with repeated measures between DcatCTI
and II, Sidak’s multiple comparison; neuron: n = 8; HEK: n = 18; mean ± SD). (C)
schematic of individual constructs of δ-catenin with indicated deletions between 301400 aa (the numbers of the construct name reflect amino acid numbers for the deletion on mouse δ-catenin). The thin line between black bars indicates the deletion area
for each construct. The highlighted region and red dot line indicate 351-440 aa and
390-391 aa of mouse δ-catenin (D) Immunoblot for in vitro generation of DcatCT in
HEK cells transfected with indicated δ-catenin deletion constructs (N ≥ 3).
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δ-catenin affects dendritic protrusion density

We sought to examine the functional role of calpain- and NMDAR-mediated
cleavage of δ-catenin. To this end, we took advantage of the constructs of δ-catenin described in Fig. 16C that are resistant to calpain-mediated cleavage, particularly the 3
constructs DI321420, DI321440 and DI391435. We have previously demonstrated that
knockdown of δ-catenin leads to an increase in excitatory spine density that is accompanied by an increase of mEPSC frequency [33]. Similar results are observed in primary
neurons from the Dcat N-term mice [33].
Primary rat neurons in culture (DIV 12) were transfected with vector, shRNA to δcatenin (δ-cat shRNA) or shRNA with either wild-type δ-catenin or the three calpain-resistant forms of δ-catenin. Neurons were fixed at DIV 18 and dendritic protrusion densities were examined by confocal microscopy (Fig. 17A). In neurons expressing δ-cat
shRNA, there was a significant increase in the density of dendritic protrusions that could
be rescued by the introduction of full-length δ-catenin. We performed a similar analysis
in neurons expressing shRNA and either of the three calpain-resistant constructs of δcatenin. Our data demonstrate that the DI321420 can significantly rescue the shRNA
knockdown phenotype (Fig. 17B). However, the DI391435 construct demonstrates borderline rescue and the DI321440 does not rescue, however, the p-values are very close
to being significant (p = 0.0504). This led us to believe that there might be population differences within the groups and not taking these different populations in account might be
obscuring significant data. Dendritic protrusions have various width and length partly reflecting synapses at different levels of maturity or development [62,63]. To assess the
distribution of various groups of dendritic protrusions, we examined the protrusion popu-
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lation in vector expressing neurons and classified them into three groups based on protrusion length and width (Fig. 17C). These groups were classified as population 1 (P1),
width ≤ 0.5 µm and length ≤ 1 µm; population 2 (P2): width ≤ 0.5 µm and length > 1 µm;
population 3 (P3): width > 0.5 µm. According to the previous publications [62], these
three populations, P1, P2 and P3, include stubby and short-thin spines or filopodia, long
thin-spines or filopodia and mushroom spines respectively. We examined the distribution
of dendritic protrusions in these three populations in neurons from vector, δ-cat shRNA
or δ-catenin groups (Fig. 17D). In neurons expressing δ-cat shRNA, the density of dendritic protrusions classified into either of the three categories was increased with δcatenin knockdown. The effects of the knockdown on P1 an P2 could be significantly
rescued by the wild-type δ-catenin. We similarly examined the ability of the three calpain-resistant constructs of δ-catenin to rescue the increase in protrusion density induced by δ-catenin knockdown in the P1 and P2 groups of protrusions (Fig. 17D). The
increase in protrusion density mediated by δ-cat shRNA was rescued by the DI321420
and DI391435, which still can be partially cleaved; but not DI321440, which inhibits
cleavage on both sites, in the P1 protrusions while the DI321420 and DI321440 but not
DI391435 rescued the phenotype of δ-catenin knockdown in the P2 protrusions. These
results indicate that the calpain cleavage is necessary for the ability of δ-catenin to regulate the density of the P1 protrusions. The phenotype of the P2 protrusions may be
slightly more complex and may reflect incomplete or partial calpain cleavage and needs
further investigation.
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Figure 17: Cleavage of δ-catenin regulates the dendritic protrusion density.
(A) Representative images of dendritic segments from hippocampal neurons transfected with vector, δ-catenin shRNA (δ-cat shRNA), DI321420, DI321440, DI391435
and δ-catenin. (B) Quantification of the density of dendritic protrusion for each group.
The densities were normalized to the geometric mean of the vector group in each experiment (Kruskal-Wallis test, Dunn’s multiple comparison test: vector, δ-catenin
shRNA and δ-catenin (grey); δ-catenin shRNA, DI321420, DI321440 and DI391435
(black). 59-80 neurons per group from 4 independent experiments; median ± 25/75%
(box) and min/max (whisker)).
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(C) Criteria for separation of dendritic protrusion into three groups. Individual dendritic
protrusions from the vector group represented by a dot and plotted according to the
width (x-axis) and length (y-axis) in the top-middle panel. The frequency distribution of
the width of all the protrusions are shown in the bottom-middle panel and a threshold
was drawn (red line) to separate the protrusions into two populations, P1+P2 and P3,
according to the difference in distribution. The frequency distribution of the length of
P1+P2 is shown in the left panel and a threshold was drawn (blue line) to separate
the population into two, P1 and P2, according to the difference in distribution. The distribution of population in each of the P1-3 population is shown on the right panel.
3443 protrusions from 4 independent experiments. (D) Quantification of the approximate density of each population of dendritic protrusions in groups indicated. The densities were normalized to the median of the vector group in each experiment (KruskalWallis test, Dunn’s multiple comparison test: vector, δ-catenin shRNA and δ-catenin
for all populations (grey); δ-catenin shRNA, DI321420 and DI321440, DI391435 for
P1 and P2 (black). 50-72 neurons per group from 4 independent experiments; median
± 25/75% (box) and min/max(whisker)).

59
We further characterized the effects of the calpain-resistant form of δ-catenin on
the P1 protrusions. The density of the P1 protrusions can be defined as the product of
the percentage of P1 protrusions in the whole population and the dendritic protrusion
density (see methods). Thus, the increase in the density of P1 protrusions with knockdown of δ-catenin could be a function of increase of one or both of these parameters. To
examine this relationship, we plotted the dendritic protrusion density and P1 percentage
for individual neurons from each group (Fig. 18A). The heatmap indicates the density of
the P1 protrusions in each group (Fig. 18A). In neurons expressing vector, the percentage of the P1 protrusions decreased with an increase in the density of protrusions. One
possible explanation of this observation is that there is an upper limit to the density of P1
protrusions in individual dendrite. If such a limit exists, the prediction would be that (1) a
threshold can be drawn with the density of P1 protrusions and the majority of dendrite
should have a density of P1 protrusions that fall below the threshold; (2) frequency distribution of density of P1 protrusions from all the dendrite would demonstrate a non-parametric distribution and a small population of dendrite would pass the threshold.

According to these criteria, we defined a threshold by examining the frequency
distribution of the density of P1 protrusions in the vector group by bootstrapping analysis
(Fig. 18B). This threshold defines the predicted upper limit of the density of P1 protrusions in the vector group. Thus, we define two populations of P1 density, one above and
one below the threshold. Once we define this threshold, we sought to examine if the
fraction of P1 density above the threshold differ in neurons expressing δ-cat shRNA or
the different constructs described above by bootstrapping (Fig. 18C). In neurons expressing δ-cat shRNA, the fraction of P1 protrusions that were above the threshold were
significantly increased compared to vector. This knockdown phenotype could be rescued
by all the constructs, including wild-type δ-catenin, but not the DI321440. These results
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are consistent with the model in which δ-catenin regulates the upper limit of density of
P1 protrusions in each neuron and mechanically requires calpain-mediated cleavage to
perform this functional role.
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Figure 18: Cleavage of δ-catenin regulates the upper limit of the density of P1
protrusions.
(A) Relationship between the percentage of P1 protrusion and dendritic protrusion
density in each group. Individual neurons from each group are represented by a dot
and plotted according to the normalized dendritic protrusion density (x-axis) and normalized P1 fraction (y-axis). The normalized approximate P1 density of each neuron
is indicated by heatmap. The P1 fraction were normalized to the median of the vector
group in each experiment (50-72 neurons per group from 4 independent experiments). The P1 density threshold is indicated by the blackline.
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(B) Estimation of the P1 density threshold. Probability density estimates were calculated from the normalized approximate P1 density from resampling the vector group
(black line; 72 neurons from 4 independent experiments) and a threshold was estimated and is indicated by a red dot line. (C) Bootstrap comparison of the fraction of
neurons with above threshold P1 density in groups indicated (p-value are calculated
by bootstrap paired t-test with δ-cat shRNA, with Bonferroni-Dunn correction, 50-72
neurons per group from 4 independent experiments, median ± CIs).
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Discussion

In this study, we have made several important observations: (1) multiple
novel forms of δ-catenin that include only the N-terminal region (DcatNT) or C-terminal
region (DcatCT) are differentially expressed in different regions of the brain; (2) some
forms of DcatCT and NT are generated by an NMDAR, Ca2+ and calpain-dependent
mechanism; (3) some forms of DcatCT and NT are generated by an NMDAR-independent, but lysosome-dependent mechanism; (4) the DcatCT and NT forms can be degraded by independent mechanisms; (5) δ-catenin regulates the density of a subpopulation of dendritic protrusions and this ability of δ-catenin is dependent on the domain of δcatenin that includes the predicted calpain cleavage site. These studies thus identify endogenous novel forms of δ-catenin and establish a functional role associated with these
forms.

Different forms of δ-catenin
Our data demonstrate that novel forms of δ-catenin, DcatCT and NT, are expressed differentially in different regions of the brain. While our studies have focused on
the cortex and the hippocampus, the expression of these forms in different regions of the
brain implies that they may have additional functional roles that may or may not be related to synaptic regulation. Our data clearly demonstrate that some forms of DcatCT
and NT are generated by calpain-mediated cleavage (Fig. 7-8). However, some forms of
DcatCT and NT may or may not be dependent on typical calpain for generation (Fig. 13).
The lysosome is an organelle that allows for protein degradation in an acidic environment. Our data, in this regard is surprising, show lysosomal function regulates both generation and degradation of basal forms of DcatCT and the generation of basal forms of
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DcatNT. Certainly, other mechanisms that might allow the generation of these forms exist, including translational or proteolytic mechanisms.
We note that there are multiple forms of DcatCT and NT that differ slightly in size.
Based on the differences in the molecular weights, we predict that these forms differ
from each other by about 50-70 aa. While these differences are small, they are sufficient, in theory, to allow differential functions for the different forms, especially via mechanisms that involve post-translational modifications or protein-protein interactions.
One possible proteolytic mechanism that may allow cleavage of δ-catenin to generate the basal forms of DcatCT and NT may be via an atypical calpain-dependent
mechanism. Much less is known about the atypical calpains in comparison to the typical
calpains. There are six members of atypical calpain [56]. In the brain, calpain 5, 7, 10
and 15 are expressed in different regions, including hippocampus and cortex [24,25,64–
66]. It is unclear if the typical calpain inhibitors, including MDL28170, are effective in
blocking the activity of atypical calpains similar to typical calpain [60,61]. Our data
demonstrate that MDL28170 is unable to inhibit the basal generation of SBDP, a known
cleavage product of the typical calpains [67]. This suggests that either the typical calpains are negligibly activated in unstimulated cortical neurons or basal generation of
SBDP is mediated by proteases that are similar in substrate-specificity to calpain. One
possibility is that this protease includes members of the atypical calpain family. Further
experimental verification is necessary to address these possibilities.
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Differential regulation of DcatCT and NT levels by degradation
Our data indicate that the two forms of δ-catenin, DcatCT and NT, can be differentially degraded. Our data also demonstrate that inability to cleave δ-catenin has detrimental consequences on the density of a subset of dendritic protrusions in hippocampal
neurons. However, our studies do not exclude the possibility that the two forms DcatCT
and NT have additional functional roles that are unique to each form. The C-terminal of
δ-catenin includes regions that are necessary for cadherin binding and PDZ-interactions
and a predicted NLS motif [57]. This region also includes the palmitoylation site on δcatenin [34] that is key for the ability of δ-catenin to regulate synaptic plasticity. The Cterminal half of the protein likely also contains interaction sites for other currently unidentified proteins. Similarly, the N-terminal region of δ-catenin includes the interaction sites
for DIPA family of proteins [68]. Further, the cleaved DcatCT and NT are likely structurally distinct from the full-length protein thus allowing for differential interactions with other
proteins. Thus, it is certainly possible that the cleaved forms of δ-catenin have additional
functional roles that are distinct from the full-length forms. The use of cleaved forms of
proteins to perform functional roles that are different from the full-length protein is widely
used by different cell types [69–72]. Such functional roles for δ-catenin remain to be
identified and are likely to be of great interest to neural circuit formation and function in
the developing brain.

Regulation of dendritic protrusions by proteolytic cleavage of δ-catenin
Our data indicate that knockdown of δ-catenin predominantly increases the populations of two groups of dendritic protrusions, the P1 and P2, represent the stubby and
short thin-spines or filopodia, and long thin-spines or filopodia respectively. The increase
in the percentage of the P1 protrusions with knockdown of δ-catenin cannot be rescued
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by constructs that lack the region that includes the calpain cleavage site, suggesting that
this region is necessary for the ability of δ-catenin to regulate the density of P1 protrusions. The increase in the density of P2 observed with knockdown of δ-catenin can be
rescued by constructs that lack the calpain cleavage site and the full-length δ-catenin
protein, indicating that the full-length protein regulates the density of P2 independent of
the ability of δ-catenin to be cleaved while the functional effects of δ-catenin on P1 protrusions require it to be proteolytically processed. Thus, δ-catenin can differentially regulate the density of two subgroups of dendritic protrusions in a manner dependent on its
ability to be subjected to proteolytic regulation. This is a novel mechanism for regulating
densities of different protrusion populations by regulation of a single molecule.
The P1 population includes stubby spines and short thin-spines and short filopodia. The short filopodia likely represent an intermediate stage along the process of protrusion formation or elimination. While the stubby and short-thin spines are expected to
have active synapses [62,73], the stability of both these populations requires contact-dependent mechanisms [62,63]. Our data indicate that the cleavage of δ-catenin is directly
linked to the upper limit of the density of protrusions as defined by the P1 population.
This implies that neurons have an inherent mechanism to regulate the density of this
class of protrusions. To do this, it is essential that the neuron has the ability to compute
the density of protrusions and evaluate if the density of P1 protrusions is close to the upper limit and initiate a cascade of events that maintains the density of these protrusions.
How δ-catenin participates in this computation and contributes to regulating the density
of P1 protrusions is not entirely clear. However, it is tempting to speculate that synaptic
inputs from NMDAR contributes to this evaluation process. While our data do not provide
direct evidence for a direct functional role for cadherin-mediated regulation of these processes in the ability of δ-catenin to regulate protrusion subpopulations, it is tempting to
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speculate that proteolytic regulation of δ-catenin modulates its ability to interact with cadherin and influence the adhesive properties of cadherin thereby indirectly influencing
synaptic contacts. Further, since the cadherin-catenin complex is linked to the actin cytoskeleton [2], the alterations in the interactions between δ-catenin and cadherin could, in
theory, promote signaling to the actin cytoskeleton thereby influencing protrusion density
or stabilization. Similarly, since δ-catenin associated with cadherin binds to several PDZ
domain-containing synaptic proteins [57], it is possible that cleavage of δ-catenin influences its association with PDZ domain scaffolding proteins thus impacting synapse assembly or disassembly.

In summary, we have identified novel forms of δ-catenin that are differentially
regulated both in terms of their generation and degradation by protease- and lysosomedependent mechanisms. Further, we have identified a functional role for these forms in
regulating the density of a subgroup of dendritic protrusions. Taken together with previous data [33], these data suggest that δ-catenin is a critical regulator of excitatory synapses in central neurons and thus a critical regulator of neural circuit formation in the developing brain. More recent data indicate that loss of δ-catenin correlates with intellectual disability and mutations in CTNND2 encoding δ-catenin have been identified in autism [32]. We propose that loss of δ-catenin in intellectual disability or autism mutations
perturb its ability to regulate excitatory synapses thus perturbing neural circuit formation
and contributing to the behavioral deficits observed in these disorders. Identifying how
autism mutations in CTNND2 perturb neural circuit formation and function will likely have
a great impact on our ability to pharmacologically intervene for therapy in this and related forms of autism and related disorders.
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Future directions
Identify regulatory mechanisms for δ-catenin cleavage
δ-catenin can be divided into multiple pools including those associated with cadherin and a nuclear pool [57]. Further, the protein has multiple sites that can be posttranslational modified [57]. Since calpain likely recognizes its substrates by recognizing
a 3D structure and not a sequence of amino acids [56], the 3D structure of δ-catenin is
likely to be critical for its ability to serve as a substrate for calpain. Association with cellular molecules in different cellular compartments and post-translational modifications
could alter the 3D structure of δ-catenin thus likely altering its susceptibility to calpainmediated cleavage and downstream functional roles. While our data identify a pool of δcatenin that is cleaved and regulates dendritic protrusions, it does not exclude the possibility that other pools of δ-catenin are similarly cleaved. It would be interesting to identify
the pools of δ-catenin that are in a conformation that make it vulnerable to calpain cleavage and identify the functional roles of this cleavage in diverse cellular compartments
and brain regions.

Identify the functional consequence for calpain-mediated cleavage of δ-catenin in excitotoxicity
Extra glutamate is released into synaptic cleft and induce excitotoxicity in different disease models, for example epilepsy, traumatic brain injury and stroke [74,75]. Extensive studies have been done on targeting calpain-mediated cleavage for neural protection under these disease conditions [55,56]. Besides preventing neural death, it is
also crucial to prevent synaptic damage and preserve the normal neural function and
connectivity under excitotoxicity conditions. δ-catenin is known to be a structural component of dendritic protrusions [57], it is unclear whether the increase δ-catenin cleavage
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mediated by calpain is a consequence or a protective mechanism for excitotoxicity in
neurons. By inducing excitotoxicity on neurons with calpain-resistant δ-catenin, we will
get a better understanding on the functional consequence of δ-catenin cleavage in neurotoxicity and how to prevent synaptic damage by regulating δ-catenin cleavage by calpain.

Identify the mechanism for the basal generation of DcatCT and NT
Our data demonstrate the basal and NMDAR-dependent generation of DcatCT
and NT are mediated via two independent pathways. Although we demonstrate that the
basal generation is regulated by lysosome function, the exact mechanism is entirely unclear. Since there is currently no evidence of lysosomal localization of δ-catenin, the basal generation of DcatCT and NT could be localized in other subcellular compartments
and regulated by signal modulators from lysosome. Since lysosome is an important organelle for cellular processes, it would not be a surprise that it plays a critical role in regulating dendritic protrusion development. However, little is known about this process
[76,77]. Thus, by understanding the mechanism for basal generation of DcatCT and NT,
we can provide a new link between lysosome and dendritic protrusion development.
Moreover, by understanding the downstream regulators of lysosome, diagnostic tools
and therapeutic targets could be developed.

Identify additional functional roles for DcatCT and NT
Our data indicate that DcatCT and NT are differentially expressed and regulated
in different regions of the brain. This raises the possibility that in addition to the functional roles we have described, the DcatCT and NT forms may have additional functional
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roles that are unique to each form. To address these questions, it is necessary to identify
the subcellular localization and distribution of these forms in neurons and establish
mouse models that express or lack these forms in a conditional manner. The availability
of this data and tools would allow the dissection of additional functional roles that might
be performed by these variants.

Implications for autism
Mutations in CTNND2 have been identified in autism. These mutations are point
mutations and span the entire length of the protein and do not show preference for a single domain of the protein suggesting that they may vary in their inability to participate in
neuronal functions. It would be interesting to examine the ability of these mutations to
be cleaved by calpain and establish how these mutations affect the ability of δ-catenin to
participate in synaptic regulation. Interestingly, the R454H mutation is in close proximity
to the predicted region of calpain cleavage. It is tempting to speculate that the presence
of this mutation will alter the 3D structure of δ-catenin and thus alter its ability to serve as
a substrate for calpain and regulate synapses. Such studies would highly benefit from
the availability of mouse models that harbor this mutation in CTNND2.
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